glp 1 france becomes first EU country to reimburse anti-obesity drugs: Minister | World News The trillion-dollar GLP-1 fiscal opportunity

Data from the meta-analysis by Elkin et al

Even when discounts are available, coverage is increasingly restricted by: Strict prior authorization requirements Step-therapy mandates Employer plan exclusions State Medicaid budget limitations Data also shows that many patients regain weight after stopping GLP-1 medications, reinforcing concerns that these drugs may function more as a long-term maintenance therapy rather than a finite treatment

Individuals with underlying gastrointestinal conditions may experience more pronounced symptoms and should consult healthcare providers before initiating supplementation

N.HajjiN.YehF